Aprecia Pharmaceuticals
Mason, Ohio, United States
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Aprecia Pharmaceuticals
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Mason, Ohio, United States
- Website
- https://aprecia.com/
- Modalities
- Oral Solid Dose, Clinical Trial Manufacturing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Aprecia Pharmaceuticals
Aprecia Pharmaceuticals is a contract development and manufacturing organization (CDMO). Capabilities: Oral Solid Dose, Clinical Trial Manufacturing. 1 manufacturing site registered with the U.S. FDA. Website: https://aprecia.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Aprecia Pharmaceuticals FDA Inspection History
2025-03
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-03-21 |
Aprecia Pharmaceuticals, LLC
Mason, Ohio
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Aprecia Pharmaceuticals FDA 483 Findings 2 observations · 2025-03-21 → 2025-03-21 ?
By subsystem
By severity
- 3 — Moderate: 1
- 2 — Minor: 1
- Repeat observations: 0
Most severe findings
-
Complete test data included in records
"Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards."
-
Component identification test
"Specific identification tests are not conducted on components that have been accepted based on the supplier's report of analysis."
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Aprecia Pharmaceuticals
How many FDA inspections does Aprecia Pharmaceuticals have on record?
CDMO Signal tracks 1 FDA inspection for Aprecia Pharmaceuticals, sourced from the FDA inspection database. See the full inspection history above.
Has Aprecia Pharmaceuticals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Aprecia Pharmaceuticals.
Does Aprecia Pharmaceuticals have a CDMO Signal Score?
Not yet. Aprecia Pharmaceuticals is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Aprecia Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare Aprecia Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
PCI Pharma Services
Bedford, NH, United States · Tredegar, United Kingdom
Sterile Fill-Finish, Biologics, Oral Solid Dose, Clinical Trial Manufacturing, Packaging & Labeling
Intertek Melbourn (formerly Melbourn Scientific)
Melbourn, Royston, United Kingdom
Clinical Trial Manufacturing, Inhalation & Nasal, Oral Solid Dose, Non-sterile Liquids, Semi-solids & Liquids
Quality Chemical Laboratories
Wilmington, North Carolina, United States
Clinical Trial Manufacturing, Oral Solid Dose, Sterile Fill-Finish, Lyophilization
Meribel Pharma Solutions
United Kingdom
Oral Solid Dose, Lyophilization, Semi-solids & Liquids, Non-sterile Liquids, Clinical Trial Manufacturing
UI Pharmaceuticals
Iowa City, Iowa, United States
Sterile Fill-Finish, Lyophilization, Oral Solid Dose, Clinical Trial Manufacturing
Compare Aprecia Pharmaceuticals with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.